Cyproheptadine: Difference between revisions
Neil.m.young (talk | contribs) No edit summary |
Neil.m.young (talk | contribs) No edit summary |
||
| Line 33: | Line 33: | ||
==Mechanism of Action== | ==Mechanism of Action== | ||
* | * Histamine-1 receptor antagonist | ||
*5-HT1A and 5-HT2A (seritonin) antagonistic properties | |||
*Weak anticholinergic activity | |||
==Comments== | ==Comments== | ||
Revision as of 12:47, 12 January 2016
Uses
- Treatment of serotonin syndrome
Administration
- Dosage Forms: 4 mg tab, 2 mg/5ml solution
- Routes of Administration: oral
- Common Trade Names: Periactin or Peritol
Adult Dosing
- initial dose of 12 mg is recommended, followed by 2 mg every two hours until clinical response is seen
Pediatric Dosing
- Children younger than two years can be given approximately 0.06 mg/kg per dose every six hours, if needed (not to exceed 0.25 mg/kg/day).
- Children two to six years can be given 2 mg every six hours, if needed (not to exceed 12 mg/day).
- Children 7 to 14 years can be given 4 mg every six hours, if needed (not to exceed 16 mg/day).
Special Populations
Renal Dosing
- No recommendations
Hepatic Dosing
- No recommendations
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- Hypotension
Common
- Sedation
Mechanism of Action
- Histamine-1 receptor antagonist
- 5-HT1A and 5-HT2A (seritonin) antagonistic properties
- Weak anticholinergic activity
Comments
See Also
References
- 1. Boyer EW. Serotonin syndrome. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. (Accessed on January 11, 2016.)
